N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial (Q36139749)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial |
scientific article |
Statements
1 reference
N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial (English)
1 reference
1 reference
Zhi-Wei Lai
1 reference
Robert Hanczko
1 reference
Eduardo Bonilla
1 reference
Tiffany N Caza
1 reference
Brandon Clair
1 reference
Adam Bartos
1 reference
Gabriella Miklossy
1 reference
Edward Doherty
1 reference
Hajra Tily
1 reference
Lisa Francis
1 reference
Ricardo Garcia
1 reference
Maha Dawood
1 reference
Jianghong Yu
1 reference
Irene Ramos
1 reference
Ioana Coman
1 reference
Paul E Phillips
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference